COMPANY WORKBOOK · DXCM
DexCom, Inc.
Healthcare & Life Sciences · N/A
$89.17-0.20%
69/100
INTERACTIVE PRICE CHART
Trend and moving averages
RELATIVE PERFORMANCE
DXCM versus SPY and SMH
Indexed to 100
Cross-sectional ranking
Scores are percentile-ranked against the current Young Bull universe and stored by date in PostgreSQL.
Healthcare & Life Sciences
This company is available as a market-data workbook. Young Bull has not added a manual investment thesis for it yet.
MODEL READ
Overall score: 68.6. Last ranked 2026-09-22.
QUARTERLY FUNDAMENTALS
Revenue and earnings power
TRAILING P/E34.48
PRICE / SALES6.68
EV / EBITDA20.79
BOOK VALUE6.95
GROSS MARGINN/A
PROFIT MARGIN20.1%
RETURN ON EQUITY38.5%
FREE CASH FLOWN/A
Profitability trend
What it does
DexCom, Inc. is a company that develops, manufactures, and distributes continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with headquarters in San Diego, California, and has a manufacturing facility in Mesa, Arizona.
PRIMARY SOURCES